Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NVAX |
---|---|---|
09:32 ET | 40403 | 12.29 |
09:34 ET | 34969 | 12.22 |
09:36 ET | 35834 | 12.2534 |
09:38 ET | 30090 | 12.2899 |
09:39 ET | 74614 | 12.33 |
09:41 ET | 22029 | 12.28 |
09:43 ET | 20226 | 12.31 |
09:45 ET | 13582 | 12.32 |
09:48 ET | 21742 | 12.3924 |
09:50 ET | 32931 | 12.35 |
09:52 ET | 21926 | 12.28 |
09:54 ET | 30288 | 12.23 |
09:56 ET | 26402 | 12.31 |
09:57 ET | 31438 | 12.18 |
09:59 ET | 24827 | 12.23 |
10:01 ET | 27223 | 12.3 |
10:03 ET | 19721 | 12.26 |
10:06 ET | 15201 | 12.24 |
10:08 ET | 7344 | 12.28 |
10:10 ET | 21140 | 12.295 |
10:12 ET | 21201 | 12.3113 |
10:14 ET | 12869 | 12.27 |
10:15 ET | 13018 | 12.305 |
10:17 ET | 7217 | 12.27 |
10:19 ET | 6285 | 12.2724 |
10:21 ET | 7459 | 12.31 |
10:24 ET | 23929 | 12.355 |
10:26 ET | 12084 | 12.35 |
10:28 ET | 24289 | 12.35 |
10:30 ET | 12165 | 12.36 |
10:32 ET | 15655 | 12.32 |
10:33 ET | 15691 | 12.31 |
10:35 ET | 12077 | 12.345 |
10:37 ET | 18765 | 12.39 |
10:39 ET | 32195 | 12.42 |
10:42 ET | 21562 | 12.4 |
10:44 ET | 96410 | 12.48 |
10:46 ET | 63898 | 12.54 |
10:48 ET | 24302 | 12.57 |
10:50 ET | 55700 | 12.64 |
10:51 ET | 47225 | 12.69 |
10:53 ET | 73741 | 12.58 |
10:55 ET | 35150 | 12.5643 |
10:57 ET | 17563 | 12.55 |
11:00 ET | 32645 | 12.52 |
11:02 ET | 38092 | 12.52 |
11:04 ET | 4122 | 12.525 |
11:06 ET | 12850 | 12.53 |
11:08 ET | 8823 | 12.555 |
11:09 ET | 26414 | 12.58 |
11:11 ET | 34812 | 12.62 |
11:13 ET | 18033 | 12.62 |
11:15 ET | 32536 | 12.62 |
11:18 ET | 33149 | 12.7 |
11:20 ET | 22854 | 12.71 |
11:22 ET | 73391 | 12.765 |
11:24 ET | 59936 | 12.76 |
11:26 ET | 24723 | 12.74 |
11:27 ET | 16155 | 12.655 |
11:29 ET | 43401 | 12.69 |
11:31 ET | 15046 | 12.71 |
11:33 ET | 11576 | 12.745 |
11:36 ET | 20240 | 12.76 |
11:38 ET | 7879 | 12.75 |
11:40 ET | 38242 | 12.705 |
11:42 ET | 63904 | 12.71 |
11:44 ET | 9125 | 12.75 |
11:45 ET | 20546 | 12.77 |
11:47 ET | 63881 | 12.825 |
11:49 ET | 34523 | 12.85 |
11:51 ET | 32283 | 12.82 |
11:54 ET | 15121 | 12.79 |
11:56 ET | 11831 | 12.85 |
11:58 ET | 13359 | 12.883835 |
12:00 ET | 36771 | 12.825 |
12:02 ET | 5998 | 12.85 |
12:03 ET | 21281 | 12.85 |
12:05 ET | 22577 | 12.87 |
12:07 ET | 5241 | 12.835 |
12:09 ET | 32960 | 12.755 |
12:12 ET | 22508 | 12.8 |
12:14 ET | 11163 | 12.82 |
12:16 ET | 13343 | 12.745 |
12:18 ET | 20287 | 12.7995 |
12:20 ET | 13323 | 12.8 |
12:21 ET | 18441 | 12.83 |
12:23 ET | 50189 | 12.865 |
12:25 ET | 24758 | 12.885 |
12:27 ET | 21291 | 12.92 |
12:30 ET | 16128 | 12.915 |
12:32 ET | 25795 | 12.92 |
12:34 ET | 127132 | 12.96 |
12:36 ET | 51011 | 13.0243 |
12:38 ET | 59890 | 13.0402 |
12:39 ET | 24366 | 13.08 |
12:41 ET | 80833 | 13.19 |
12:43 ET | 59215 | 13.08 |
12:45 ET | 65394 | 13.1457 |
12:48 ET | 24553 | 13.135 |
12:50 ET | 21993 | 13.175 |
12:52 ET | 49367 | 13.17 |
12:54 ET | 16222 | 13.1605 |
12:56 ET | 36411 | 13.14 |
12:57 ET | 58656 | 13.14 |
12:59 ET | 21030 | 13.15 |
01:01 ET | 10531 | 13.135 |
01:03 ET | 26536 | 13.0813 |
01:06 ET | 37700 | 13.0899 |
01:08 ET | 13437 | 13.08 |
01:10 ET | 21167 | 13.0316 |
01:12 ET | 19557 | 13.0676 |
01:14 ET | 16940 | 13.08 |
01:15 ET | 28816 | 13.155 |
01:17 ET | 70128 | 13.205 |
01:19 ET | 58050 | 13.275 |
01:21 ET | 32204 | 13.24 |
01:24 ET | 11879 | 13.1712 |
01:26 ET | 23084 | 13.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Novavax Inc | 1.9B | -4.8x | --- |
PTC Therapeutics Inc | 2.9B | -6.0x | --- |
ACADIA Pharmaceuticals Inc | 2.6B | 88.6x | --- |
Azenta Inc | 2.4B | -17.6x | --- |
Guardant Health Inc | 2.8B | -5.7x | --- |
P3 Health Partners Inc | 136.6M | -0.7x | --- |
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
---|---|
Revenue (TTM) | $987.7M |
Shares Outstanding | 160.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.03 |
EPS | $-2.76 |
Book Value | $-5.14 |
P/E Ratio | -4.8x |
Price/Sales (TTM) | 2.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -29.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.